RAP1A and cancer: These studies show that CFH is essential to control the activation of complement in the liver and may represent a new diagnostic and prognostic marker of liver cancer; RAS-associated protein 1 (RAP1) is a member of telomere-binding proteins, which has been proved to be related to the occurrence, development and chemoresistance of human cancer (48).